Lupin and Aurobindo Pharma have been recommended for hold by research house Prabhudas Lilladher. Target price for Aurobindo Pharma has been suggested Rs 511.
The market is at an all-time high but both macros and micros are not supporting the current bull run where the current momentum in the index is majorly driven by global liquidity as global interest